Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 519

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications

Open access
Mathur, Anurag, Loskill, Peter, Shao, Kaifeng, Huebsch, Nathaniel, Hong, SoonGweon, Marcus, Sivan G., Marks, Natalie, Mandegar, Mohammad, Conklin, Bruce R., Lee, Luke P., Healy, Kevin E.·2015·Scientific Reports

Abstract

Drug discovery and development are hampered by high failure rates attributed to the reliance on non-human animal models employed during safety and efficacy testing. A fundamental problem in this inefficient process is that non-human animal models cannot adequately represent human biology. Thus, there is an urgent need for high-content in vitro systems that can better predict drug-induced toxicity. Systems that predict cardiotoxicity are of uppermost significance, as approximately one third of safety-based pharmaceutical withdrawals are due to cardiotoxicty. Here, we present a cardiac microphysiological system (MPS) with the attributes required for an ideal in vitro system to predict cardiotoxicity: i) cells with a human genetic background; ii) physiologically relevant tissue structure (e.g. aligned cells); iii) computationally predictable perfusion mimicking human vasculature; and, iv) multiple modes of analysis (e.g. biological, electrophysiological and physiological). Our MPS is able to keep human induced pluripotent stem cell derived cardiac tissue viable and functional over multiple weeks. Pharmacological studies using the cardiac MPS show half maximal inhibitory/effective concentration values (IC 50 /EC 50 ) that are more consistent with the data on tissue scale references compared to cellular scale studies. We anticipate the widespread adoption of MPSs for drug screening and disease modeling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep08883

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 30

  1. Mathur, A. et al. Human induced pluripotent stem cell-based microphysiological tissue models of myocardium and liver for drug development. Stem cell research & therapy 4 Suppl 1, S14 (2013). · DOI
  2. Scott, C. W., Peters, M. F. & Dragan, Y. P. Human induced pluripotent stem cells and their use in drug discovery for toxicity testing. Toxicol Lett 219, 49–58 (2013). · DOI
  3. Chi, K. R. Revolution dawning in cardiotoxicity testing. Nature reviews. Drug discovery 12, 565–567 (2013). · DOI
  4. Liang, P. et al. Drug Screening Using a Library of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals Disease-Specific Patterns of Cardiotoxicity. Circulation 127, 1677–1691 (2013). · DOI · Paper page
  5. Grosberg, A., Alford, P. W., McCain, M. L. & Parker, K. K. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. Lab on a chip 11, 4165–4173 (2011). · DOI · Paper page
  6. Boudou, T. et al. A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues. Tissue engineering. Part A 18, 910–919 (2012). · DOI · Paper page
  7. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007). · DOI · Paper page
  8. Braam, S. R. et al. Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes. Stem Cell Res 4, 107–116 (2010). · DOI · Paper page
  9. Guo, L. et al. Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci 123, 281–289 (2011). · DOI · Paper page
  10. Harris, K. et al. Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays. Toxicol Sci 134, 412–426 (2013). · DOI
  11. Yokoo, N. et al. The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells. Biochem Bioph Res Co 387, 482–488 (2009). · DOI
  12. Ma, Z. et al. Three-dimensional filamentous human diseased cardiac tissue model. Biomaterials 35, 1367–1377 (2014). · DOI
  13. Thavandiran, N. et al. Design and formulation of functional pluripotent stem cell-derived cardiac microtissues. Proceedings of the National Academy of Sciences of the United States of America 110, E4698–4707 (2013). · DOI · Paper page
  14. Zhang, D. et al. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes. Biomaterials 34, 5813–5820 (2013). · DOI · Paper page
  15. Kanzaki, Y. et al. Three-dimensional architecture of cardiomyocytes and connective tissue in human heart revealed by scanning electron microscopy. Circulation 122, 1973–1974 (2010). · DOI
  16. Huebsch, N. et al. Automated Video-Based Analysis of Contractility and Calcium Flux in Human-Induced Pluripotent Stem-Derived Cardiomyocytes Cultured over Different Spatial Scales. Tissue engineering. Part C, Methods 10.1089/ten.tec.2014.0283 (2014). · DOI · Paper page
  17. Costa, K. D., Takayama, Y., McCulloch, A. D. & Covell, J. W. Laminar fiber architecture and three-dimensional systolic mechanics in canine ventricular myocardium. The American journal of physiology 276, H595–607 (1999).
  18. LeGrice, I. J. et al. Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. The American journal of physiology 269, H571–582 (1995).
  19. Navarrete, E. G. et al. Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays. Circulation 128, S3–13 (2013). · DOI · Paper page
  20. Brandenburger, M. et al. Organotypic slice culture from human adult ventricular myocardium. Cardiovascular research 93, 50–59 (2012). · DOI
  21. de Boer, T. P., Camelliti, P., Ravens, U. & Kohl, P. Myocardial tissue slices: organotypic pseudo-2D models for cardiac research & development. Future cardiology 5, 425–430 (2009). · DOI
  22. Habeler, W., Peschanski, M. & Monville, C. Organotypic heart slices for cell transplantation and physiological studies. Organogenesis 5, 62–66 (2009). · DOI
  23. Redfern, W. S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovascular research 58, 32–45 (2003). · DOI · Paper page
  24. van der Valk, J. et al. Optimization of chemically defined cell culture media--replacing fetal bovine serum in mammalian in vitro methods. Toxicology in vitro: an international journal published in association with BIBRA 24, 1053–1063 (2010). · DOI · Paper page
  25. Zhu, W. Z., Van Biber, B. & Laflamme, M. A. Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. Methods in molecular biology 767, 419–431 (2011). · DOI
  26. Buchwald, P. FEM-based oxygen consumption and cell viability models for avascular pancreatic islets. Theoretical biology & medical modelling 6, 5 (2009). · DOI · Paper page
  27. Markov, D. A., Lillie, E. M., Garbett, S. P. & McCawley, L. J. Variation in diffusion of gases through PDMS due to plasma surface treatment and storage conditions. Biomedical microdevices 16, 91–96 (2014). · DOI
  28. Rana, P., Anson, B., Engle, S. & Will, Y. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. Toxicol Sci 130, 117–131 (2012). · DOI
  29. Stratton, J. R. et al. Differences in Cardiovascular-Responses to Isoproterenol in Relation to Age and Exercise Training in Healthy-Men. Circulation 86, 504–512 (1992). · DOI
  30. Matsuoka, S. et al. Comparison of Ca2+ channel inhibitory effects of cibenzoline with verapamil on guinea-pig heart. General pharmacology 22, 87–91 (1991). · doi:10.1016/0306-3623(91)90314-v

Cited by

See all 519

Metadata

Authors
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., & Healy, K. E.
Venue
Scientific Reports
Published
2015-03-09
Volume
5
Issue
1
Pages
8883-8883
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2002708055
Cited by
519
References
5
FWCI
27.37
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications. https://app.cochat.ai/papers/10.1038/srep08883
The paper
Mathur, A., Loskill, P., Shao, K., Huebsch, N., Hong, S., Marcus, S. G., Marks, N., Mandegar, M., Conklin, B. R., Lee, L. P., & Healy, K. E. (2015). Human iPSC-based Cardiac Microphysiological System For Drug Screening Applications. Scientific Reports. https://doi.org/10.1038/srep08883

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.